StockData

Aibotics, Inc. (AIBT) shareholders

AIBTOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 0/30
$0.00+0.00 (+42.86%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Ownership

Who owns Aibotics's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Harris Toby Allen137,264,09715.40%13G (passive)Sep 15, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Benjamin Nathaniel KaplanCEO, Director95,250,00011.20%Jul 28, 2025
Benjamin KaplanCEO, Director20,250,0002.38%Dec 17, 2024
Mark CroskeryDirector10,016,9121.18%Dec 17, 2024

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Benjamin Nathaniel Kaplan
CEO, Director
Jul 25, 2025Award+75,000,000––95,250,000
Mark Croskery
Director
Dec 13, 2024Award+10,000,000$0.01$100.00K10,016,912
Benjamin Kaplan
CEO, Director
Dec 13, 2024Award+20,000,000$0.01$200.00K20,250,000
Mark D. Williams
President, CEO & CFO, Director, 10% owner
Jul 28, 2020Award+500,000$50000.00$25.00B5,946,173

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 41M shares a day
Change since last report
-81.4%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Aibotics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,007,754 shares on Sep 14, 2026 over the last 90 days.

See a number that looks wrong?